Bevacizumab Restores Hearing in NF2 Patients
Bevacizumab is a cancer treatment drug. It’s meant to shrink the blood vessels going to a tumor to stop it from growing.
It was not previously tried on benign tumors because blood flow does not appear to play as big of a role in these types of growth versus the malignant ones.
Researchers tested the drug on ten people with auditory schwannomas from NF2. The tumors in nine of the patients reduced in size. Some even experienced hearing recovery.
Read more:
August 5th, 2009 at 10:05 am
[...] (more about bevacizumab) Posted in Research | [...]
August 6th, 2009 at 9:52 am
[...] about Edith Garrett’s experience with bevacizumab and how the drug helped her get her hearing back. Posted in Personal Stories [...]